Interview with the magazine “Laborjournal”
Research and development without or with significantly less animal testing must be possible. We at Dynamic42 are convinced of this and at the same time on the way to realising this goal with the help of our organ-on-chip technology.
In an interview with the trade journal “Laborjournal”, our managing directors Martin Raasch and Knut Rennert explain how the Dynamic42 biotech chips work and how the “mini-organs” used contribute to reducing animal experiments.
The article also gives exciting insights into the background of our company and explains what our company name means.
Read the full interview in German: Laborjounal online: Nerdy names and runny noses
Recommendation: The magazine reported in more detail about our technology in the print edition. Laborjournal issue 03/22 (page 46/47)
Read more News:
News
Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus
We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.
Read MoreNews
Joanna Nowacka joins Dynamic42 as Lead for Stem Cell Model Development
We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.
Read MoreNews
Press Release | Biotech company Dynamic42 launches open platform for organ model development
Dynamic42 has launched the "DynamicOrgan System", an open, flexible, and cost-effective organ-on-chip platform for lab use.
Read More